ProQR Therapeutics (PRQR) FCF Payout Ratio Growth (3y) (2016 - 2025)
ProQR Therapeutics (PRQR) FCF Payout Ratio Growth (3y) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Cover Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | - |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | - |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | - |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 9.12% |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | - |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | - |
| 10 | ProQR Therapeutics | 206.80 Mn | 111.86 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -10.07% |
| Mar 31, 2025 | 0.48% |
| Sep 30, 2024 | 5.64% |
| Jun 30, 2024 | 7.67% |
| Mar 31, 2024 | -0.94% |
| Sep 30, 2023 | -17.16% |
| Jun 30, 2023 | -11.70% |
| Mar 31, 2023 | 35.17% |
| Sep 30, 2022 | 8.09% |
| Jun 30, 2022 | -11.89% |
| Mar 31, 2022 | -1.46% |
| Dec 31, 2021 | 76.83% |
| Sep 30, 2021 | 10.19% |
| Jun 30, 2021 | -30.72% |
| Mar 31, 2021 | -42.10% |
| Dec 31, 2020 | -47.57% |
| Sep 30, 2020 | -34.51% |
| Jun 30, 2020 | -25.76% |
| Mar 31, 2020 | -45.97% |
| Dec 31, 2019 | -81.06% |